Posted on March 5, 2026

Enrolment Update- March 2026

As of March 2, 2026, the PERFORM trial has officially reached 20 enrolled patients. This early momentum is fantastic, and we want to extend a big thank you to Dr. Kenneth Gundle at the Oregon Health and Science University Hospital (OHSU), Dr. Ricardo Becker at the Hospital de Clínicas de Porto Alegre, Dr. Christopher Johnson at the Parkview Packnett Family Cancer Institute and their research teams for their contributions over the past month. We would like to recognize the exceptional efforts of the team at OHSU who achieved top enrolment this month with FOUR total enrolments. A huge thank you to Dr. Gundle, Dr. Doung, Dr. Ramsey, Rebecca Smith, and Barron Smith for their outstanding contributions!